Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke P Akard

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2017
Donor Lymphocyte Infusions Used to Treat Mixed-Chimeric and High-Risk Patient Populations in the Relapsed and Nonrelapsed Settings after Allogeneic Transplantation for Hematologic Malignancies Are Associated with High Five-Year Survival if Persistent Full Donor Chimerism Is Obtained or MaintainedLauren E Caldemeyer, Luke P Akard, John R Edwards, et al.
Mycoses|August 23, 2006
Delayed ABLC prophylaxis after allogeneic stem-cell transplantationJan Jansen, Luke P Akard, Matthew F Wack, et al.
Transfusion|May 1, 2007
Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?Eva M Jansen, Susan G Hanks, Colin Terry, et al.
Cytotherapy|January 21, 2009
Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentrationJan Jansen, Pamela L Nolan, Margaret I Reeves, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2013
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy studyLuke P Akard, Jorge E Cortes, Maher Albitar, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|March 12, 2002
Peripheral blood progenitor cell transplantationJan Jansen, James M Thompson, Michael J Dugan, et al.
Therapeutic Advances in Hematology|January 3, 2017
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinibSikander Ailawadhi, Luke P Akard, Carole B Miller, et al.
British Journal of Haematology|March 8, 2008
Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantationStefan O Ciurea, Barry Sadegi, Andrew Wilbur, et al.
Cytotherapy|May 1, 2010
Transportation of peripheral blood progenitor cell products: effect of ambient temperatureJan Jansen, Pamela L Nolan, Margaret I Reeves, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 20, 2016
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH StudyJorge E Cortes, Jeffrey H Lipton, Carole B Miller, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2017
Donor Lymphocyte Infusions Used to Treat Mixed-Chimeric and High-Risk Patient Populations in the Relapsed and Nonrelapsed Settings after Allogeneic Transplantation for Hematologic Malignancies Are Associated with High Five-Year Survival if Persistent Full Donor Chimerism Is Obtained or MaintainedLauren E Caldemeyer, Luke P Akard, John R Edwards, et al.
Mycoses|August 23, 2006
Delayed ABLC prophylaxis after allogeneic stem-cell transplantationJan Jansen, Luke P Akard, Matthew F Wack, et al.
Transfusion|May 1, 2007
Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?Eva M Jansen, Susan G Hanks, Colin Terry, et al.
Cytotherapy|January 21, 2009
Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentrationJan Jansen, Pamela L Nolan, Margaret I Reeves, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2013
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy studyLuke P Akard, Jorge E Cortes, Maher Albitar, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|March 12, 2002
Peripheral blood progenitor cell transplantationJan Jansen, James M Thompson, Michael J Dugan, et al.
Therapeutic Advances in Hematology|January 3, 2017
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinibSikander Ailawadhi, Luke P Akard, Carole B Miller, et al.
British Journal of Haematology|March 8, 2008
Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantationStefan O Ciurea, Barry Sadegi, Andrew Wilbur, et al.
Cytotherapy|May 1, 2010
Transportation of peripheral blood progenitor cell products: effect of ambient temperatureJan Jansen, Pamela L Nolan, Margaret I Reeves, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 20, 2016
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH StudyJorge E Cortes, Jeffrey H Lipton, Carole B Miller, et al.
Pageof 3